Artemis Science Inc

Immunotope Diagnostics Inc is a clinical stage biotechnology company based in Doylestown, PA, specializing in the development of immunotherapy products for the treatment and prevention of cancer and chronic viral infections. Their comprehensive approach to cancer therapy focuses on early diagnosis and the development of effective treatments that destroy tumors and prevent metastasis. Utilizing proprietary immunoproteomics technologies, Immunotope identifies naturally processed and presented antigens associated with diseased cells, activating the patient's own immune system to fight disease and prevent recurrence. With a product portfolio that includes ovarian, breast, prostate, lung, pancreatic, and colon cancer, Immunotope aims to provide highly efficacious, curative treatments with minimal toxicity, while also offering innovative tools and services for collaborative development of novel drug and diagnostic products.Generated from the website

Gfree Bio is a leading computer-aided drug design company based in Austin, Texas. With a team of experts in the field, they offer state-of-the-art modeling contract research capabilities to biotech and pharma companies, having contributed to the advancement of discovery programs at over 60 companies. Their extensive scientific and business expertise also allows them to provide effective consulting services for evaluating new technology, assisting NewCo startups, and serving as expert witnesses in patent litigation. With a focus on computer-aided drug design, Gfree Bio specializes in structure-based design, ligand-based design, cheminformatics, and emerging technologies. Their broad pharma science and business experience, combined with their dedication to delivering innovative solutions, make them a trusted partner in the field of drug discovery. Generated from the website

Bixi Life Sciences LLC is a biotechnology company based in Doylestown, PA, specializing in therapeutic drug and biomarker discovery for liver cancer and hepatitis B. Led by President and CEO Dr. Timothy M. Block, the company is supported by a team of experienced professionals and advisors who have successfully converted academic innovations into valuable companies. With a focus on converting academic innovations into commercial products, Bixi Life Sciences LLC is managed by the renowned Blumberg Institute and PA Biotech Center. Under the leadership of Dr. Block, the company pioneers the use of glycoproteomics for liver cancer biomarker detection and has made significant advancements in the discovery of antiviral drugs and biomarkers of liver cancer.Generated from the website